- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
New role for an established drug? Bisphosphonates as potential anticancer agents - Abstract
September 21, 2011
Social and clinical predictors of prostate cancer treatment decisions among men in South Carolina - Abstract
September 21, 2011
Imatinib mesylate (Gleevec) as protein-tyrosine kinase inhibitor elicits smooth muscle relaxation in isolated human prostatic tissue - Abstract
September 21, 2011
Contemporary role of prostate cancer antigen 3 in the management of prostate cancer - Abstract
September 20, 2011
Seminal vesicle biopsies: Interest in the prostate cancer staging before radiation therapy or brachytherapy - Abstract
September 20, 2011
Low risk prostate cancer in men ≥ 70 years old: To treat or not to treat - Abstract
September 20, 2011
A comprehensive bone-health management approach for men with prostate cancer receiving androgen deprivation therapy - Abstract
September 20, 2011
Efficacy of alternative antiandrogen therapy for prostate cancer that relapsed after initial maximum androgen blockade - Abstract
September 19, 2011
Imaging of prostate cancer with immuno-PET and immuno-SPECT using a radiolabeled anti-EGP-1 monoclonal antibody - Abstract
September 19, 2011
Heregulin expression and prognosis in prostate adenocarcinoma - Abstract
September 19, 2011
Dietary acrylamide and risk of prostate cancer - Abstract
September 19, 2011
Control of prostate cancer associated with withdrawal of a supplement containing folic acid, L-methyltetrahydrofolate and vitamin B12: A case report - Abstract
September 19, 2011
Transition zone PSA density improves the prostate cancer detection rate both in PSA 4.0-10.0 and 10.1-20.0 ng/ml in Chinese men - Abstract
September 19, 2011